The EFEMP1 gene: a frequent target for epigenetic silencing in multiple human pituitary adenoma subtypes

Anne Marie McNicol, Nigel A. Hibberts, David J. Simpson, William E. Farrell, Richard N. Clayton, Loss of pRb Expression in Pituitary Adenomas Is Associated with Methylation of the RB1 CpG Island Cancer Research. ,vol. 60, pp. 1211- 1216 ,(2000)

Ariane Sadr-Nabavi, Juliane Ramser, Juliane Volkmann, Joerg Naehrig, Frank Wiesmann, Beate Betz, Heide Hellebrand, Stefanie Engert, Susanne Seitz, Rene Kreutzfeld, Takako Sasaki, Norbert Arnold, Rita Schmutzler, Marion Kiechle, Dieter Niederacher, Nadia Harbeck, Edgar Dahl, Alfons Meindl, Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker. International Journal of Cancer. ,vol. 124, pp. 1727- 1735 ,(2009) , 10.1002/IJC.24108

Monica Fedele, Giovanna Maria Pierantoni, Rosa Visone, Alfredo Fusco, None, Critical role of the HMGA2 gene in pituitary adenomas. Cell Cycle. ,vol. 5, pp. 2045- 2048 ,(2006) , 10.4161/CC.5.18.3211

C Zeller, W Dai, N L Steele, A Siddiq, A J Walley, C S M Wilhelm-Benartzi, S Rizzo, A van der Zee, J A Plumb, R Brown, Candidate DNA methylation drivers of acquired cisplatin resistance in ovarian cancer identified by methylome and expression profiling Oncogene. ,vol. 31, pp. 4567- 4576 ,(2012) , 10.1038/ONC.2011.611

T.-Y. Roh, S. Cuddapah, K. Cui, K. Zhao, The genomic landscape of histone modifications in human T cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 103, pp. 15782- 15787 ,(2006) , 10.1073/PNAS.0607617103

William M. Gallagher, Caroline A. Currid, Linda C. Whelan, Fibulins and cancer: friend or foe? Trends in Molecular Medicine. ,vol. 11, pp. 336- 340 ,(2005) , 10.1016/J.MOLMED.2005.06.001

Kiren Yacqub-Usman, Alan Richardson, Cuong V Duong, Richard N Clayton, William E Farrell, None, The pituitary tumour epigenome: aberrations and prospects for targeted therapy Nature Reviews Endocrinology. ,vol. 8, pp. 486- 494 ,(2012) , 10.1038/NRENDO.2012.54

Young-Ho Kim, Han Cheol Lee, Seon-Young Kim, Young Il Yeom, Kyung Ju Ryu, Byung-Hoon Min, Duk-Hwan Kim, Hee Jung Son, Poong-Lyul Rhee, Jae J. Kim, Jong Chul Rhee, Hee Cheol Kim, Ho-Kyung Chun, William M. Grady, Yong Sung Kim, Epigenomic Analysis of Aberrantly Methylated Genes in Colorectal Cancer Identifies Genes Commonly Affected by Epigenetic Alterations Annals of Surgical Oncology. ,vol. 18, pp. 2338- 2347 ,(2011) , 10.1245/S10434-011-1573-Y

A. S. Bates, W. E. Farrell, E. J. Bicknell, A. M. McNicol, A. J. Talbot, J. C. Broome, C. W. Perrett, R. V. Thakker, R. N. Clayton, Allelic deletion in pituitary adenomas reflects aggressive biological activity and has potential value as a prognostic marker. The Journal of Clinical Endocrinology and Metabolism. ,vol. 82, pp. 818- 824 ,(1997) , 10.1210/JCEM.82.3.3799

Adil Bahar, John E Bicknell, David J Simpson, Richard N Clayton, William E Farrell, Loss of expression of the growth inhibitory gene GADD45gamma, in human pituitary adenomas, is associated with CpG island methylation. Oncogene. ,vol. 23, pp. 936- 944 ,(2004) , 10.1038/SJ.ONC.1207193